Dermal Fibroblasts, Not Keratinocytes, Dominate IL‐17A/TNF‐Driven Inflammation
Experimental Dermatology · 2026
DOI: 10.1111/exd.70232 ↗At a glance
Journal article in Experimental Dermatology, 2026. Written by Lejla Svraka and 4 co-authors. Institution: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark. Major MEDLINE topics: Interleukin-17, Keratinocytes, Fibroblasts, Tumor Necrosis Factor-alpha. Cited 2 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Aarhus Universitet, Danish Psoriasis Research Foundation, Sunhedsdonationer.
Abstract (original language)
Chronic inflammatory skin diseases such as psoriasis and hidradenitis suppurativa are driven by cytokines, including IL‐17A and TNF. Although biologics targeting these cytokines have transformed therapy, the transcriptional contributions of individual skin‐resident cell types remain unclear, and dermal fibroblasts have been largely overlooked compared with keratinocytes. To address this, we compared the transcriptional responses of primary human dermal fibroblasts and keratinocytes following in vitro stimulation with IL‐17A, TNF, or both, using bulk RNA sequencing and Western blotting. Dermal fibroblasts mounted a stronger and broader proinflammatory response than keratinocytes. This was particularly evident in response to TNF and combined TNF/IL‐17A stimulation, with enrichment for immune signalling and chemotaxis pathways and robust induction of chemokine genes, including CCL20 , CXCL8 , and IL6 . Keratinocytes primarily upregulated genes associated with epithelial differentiation, barrier function, and protein regulation, including IL36G , S100A7A , and DEFB4A . The heightened fibroblast responsiveness correlated with increased TNF sensitivity and substantially higher TNFR2 ( TNFRSF1B ) expression and signalling compared with keratinocytes, suggesting a fibroblast‐specific mechanism amplifying inflammatory responses. These findings challenge the keratinocyte‐centric view of skin inflammation and identify dermal fibroblasts as active contributors and potential therapeutic targets in TNF‐ and Th17‐driven skin diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
- Aarhus University, Aarhus, Denmark.
ORCID profiles: Lejla Svraka, Hakim Ben Abdallah, Trine Bertelsen, Christian Vestergaard, Claus Johansen
Funding
- Aarhus Universitet
- Danish Psoriasis Research Foundation
- Sunhedsdonationer
Cite
APA
Svraka, L., Abdallah, H. B., Bertelsen, T., Vestergaard, C., & Johansen, C. (2026). Dermal Fibroblasts, Not Keratinocytes, Dominate IL‐17A/TNF‐Driven Inflammation. Experimental Dermatology. https://doi.org/10.1111/exd.70232
Vancouver
Svraka L, Abdallah HB, Bertelsen T, Vestergaard C, Johansen C. Dermal Fibroblasts, Not Keratinocytes, Dominate IL‐17A/TNF‐Driven Inflammation. Experimental Dermatology. 2026. doi:10.1111/exd.70232
BibTeX
@article{Svraka2026,
author = {Svraka, Lejla and Abdallah, Hakim Ben and Bertelsen, Trine and Vestergaard, Christian and Johansen, Claus},
title = {Dermal Fibroblasts, Not Keratinocytes, Dominate IL‐17A/TNF‐Driven Inflammation},
journal = {Experimental Dermatology},
year = {2026},
doi = {10.1111/exd.70232}
}
EUVIMED